{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:49:05Z","timestamp":1782398945273,"version":"3.54.5"},"reference-count":26,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    Concentration of calprotectin in ascitic fluid has been proposed as the possible diagnostic marker for spontaneous bacterial peritonitis. This study aimed to choose the optimal preanalytical conditions for the determination of the concentration of calprotectin in ascitic fluid.\n                    <jats:bold>Materials and methods:<\/jats:bold>\n                    Study was performed using 20 samples of ascitic fluid of inflammatory etiology. Number of total nucleated (TNC) and polymorphonuclear cells (PMN) were determined on Advia 2120i (Siemens Healthineers). Ascitic samples were collected into three tube types (K2EDTA, tubes with clot activator and Li-heparin tubes) and centrifuged under three different conditions (400\u00d7g, 1500\u00d7g and 3000\u00d7g for 15 minutes). Concentration of calprotectin was determined using B\u00fchlmann\u2019s turbidimetric assay and potassium and lactate dehydrogenase using standard laboratory methods on Atellica Solution (Siemens Healthineers). Data was evaluated by Friedman test and Spearman\u2019s correlation coefficient.\n                    <jats:bold>Results:<\/jats:bold>\n                    The highest concentration of calprotectin was observed in red tubes with clot activator (centrifuged 1500\u00d7g for 15 minutes; median 0.349 mg\/L, IQR 0.094\u20131.129 mg\/L) and the lowest in lavender tubes (centrifuged 3000\u00d7g for 15 minutes; median 0.109 mg\/L, IQR: 0.037\u20130.850 mg\/L). Friedman test showed statistically significant difference between concentration of calprotectin in different preanalytical conditions (P &amp;lt; 0.001). According to the desirable biological variation criteria, differences in calprotectin concentration were clinically significantly different for different preanalytical conditions.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    To determine the concentration of calprotectin in ascites, we suggest using a test tube with a red cap and centrifugation conditions of 1500\u00d7g for 15 minutes which is consistent with the relevant national and international guidelines.\n                  <\/jats:p>","DOI":"10.11613\/bm.2026.020703","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:06:42Z","timestamp":1775722002000},"page":"279-288","source":"Crossref","is-referenced-by-count":0,"title":["Preanalytical study concerning the influence of tube type and centrifugation conditions on the concentration of calprotectin in ascites"],"prefix":"10.11613","volume":"36","author":[{"given":"Igor","family":"Alfirevi\u0107","sequence":"first","affiliation":[{"name":"University Department of Surgery, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Troskot Peri\u0107","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Referral Center for Functional Gastrointestinal Disorders of the Ministry of Health of Republic Croatia, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Vuljani\u0107","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"\u010ci\u010dak","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sara\u010devi\u0107","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrijana","family":"Doroti\u0107","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Siter-Kupre\u0161anin","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Diagnostics, University Hospital \u201cSveti Duh\u201d, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4885","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"key20260409080637_r1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/liv.14418","article-title":"Clinical features and outcomes of bacterascites in cirrhotic patients: A retrospective, multicentre study.","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"key":"key20260409080637_r2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4166\/kjg.2018.72.2.56","article-title":"Spontaneous Bacterial Peritonitis.","volume":"72","author":"Song","year":"2018","journal-title":"Korean J Gastroenterol"},{"key":"key20260409080637_r3","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.3748\/wjg.15.5505","article-title":"Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis.","volume":"15","author":"Lata","year":"2009","journal-title":"World J Gastroenterol"},{"key":"key20260409080637_r4","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.","volume":"74","author":"Biggins","year":"2021","journal-title":"Hepatology"},{"key":"key20260409080637_r5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J Hepatol"},{"key":"key20260409080637_r6","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.47391\/JPMA.EGY-S4-6","article-title":"Ascitic fluid calprotectin and ratio of calprotectin to total protein in spontaneous bacterial peritonitis.","volume":"73","author":"Fahmy","year":"2023","journal-title":"J Pak Med Assoc"},{"key":"key20260409080637_r7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ejim.ejim_41_17","article-title":"Ascitic calprotectin as a diagnostic marker for spontaneous bacterial peritonitis in hepatitis C virus cirrhotic Egyptian patients.","volume":"30","author":"Heikl","year":"2018","journal-title":"Egypt J Intern Med"},{"key":"key20260409080637_r8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s43066-020-0022-7","article-title":"Ascitic calprotectin as a useful marker in the diagnosis of spontaneous bacterial peritonitis in adults.","volume":"10","author":"Abdel Rahman","year":"2020","journal-title":"Egypt Liver J"},{"key":"key20260409080637_r9","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: from biomarker to biological function.","volume":"70","author":"Juki\u0107","year":"2021","journal-title":"Gut"},{"key":"key20260409080637_r10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12887-022-03433-9","article-title":"An evaluation of ascitic calprotectin for diagnosis of ascitic fluid infection in children with cirrhosis.","volume":"22","author":"Honar","year":"2022","journal-title":"BMC Pediatr"},{"key":"key20260409080637_r11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/00365521.2020.1794023","article-title":"Diagnostic and prognostic role of ascitic fluid calprotectin level: six-month outcome findings in cirrhotic patients.","volume":"55","author":"Nasereslami","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"key20260409080637_r12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jalm\/jfac057","article-title":"Impact of Preanalytical Factors on Calprotectin Concentration in Stool: A Multiassay Comparison.","volume":"7","author":"Hamer","year":"2022","journal-title":"J Appl Lab Med"},{"key":"key20260409080637_r13","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1515\/cclm-2021-0172","article-title":"Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammation.","volume":"59","author":"Infantino","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"key20260409080637_r14","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2020.010502","article-title":"Laboratory testing of extravascular body fluids: National recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part I \u2013 Serous fluids.","volume":"30","author":"Milevoj Kop\u010dinovi\u0107","year":"2020","journal-title":"Biochem Med (Zagreb)"},{"key":"key20260409080637_r15"},{"key":"key20260409080637_r16"},{"key":"key20260409080637_r17"},{"key":"key20260409080637_r18","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2024.030704","article-title":"Short- and long-term stability of synovial fluid calprotectin.","volume":"34","author":"\u010ci\u010dak","year":"2024","journal-title":"Biochem Med (Zagreb)"},{"key":"key20260409080637_r19","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1515\/cclm-2023-1126","article-title":"Discriminating signal from noise: the biological variation of circulating calprotectin in serum and plasma.","volume":"62","author":"Briers","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"key20260409080637_r20","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/jcla.21994","article-title":"Ascitic calprotectin is a novel and accurate marker for spontaneous bacterial peritonitis.","volume":"30","author":"Fernandes","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"key20260409080637_r21","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3748\/wjg.v19.i13.2028","article-title":"Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count.","volume":"19","author":"Burri","year":"2013","journal-title":"World J Gastroenterol"},{"key":"key20260409080637_r22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.12816\/0052252","article-title":"Comparative study of ascitic fluid and serum levels of calprotectin, procalcitonin and endocan in patients with liver cirrhosis for early diagnosis and prediction of spontaneous bacterial peritonitis.","volume":"47","author":"Kassem","year":"2018","journal-title":"Azhar Med J"},{"key":"key20260409080637_r23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10930-014-9578-6","article-title":"In solution cation-induced secondary and tertiary structure alterations of human calprotectin.","volume":"33","author":"Imani","year":"2014","journal-title":"Protein J"},{"key":"key20260409080637_r24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1373\/jalm.2017.024778","article-title":"Sample Type and Storage Conditions Affect Calprotectin Measurements in Blood.","volume":"2","author":"Pedersen","year":"2018","journal-title":"J Appl Lab Med"},{"key":"key20260409080637_r25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000545722","article-title":"Plasma Concentration of Calprotectin, but Not Serum Concentration, Is a Predictive Biomarker for Clinical Remission in Ulcerative Colitis.","volume":"10","author":"Honap","year":"2025","journal-title":"Inflamm Intest Dis"},{"key":"key20260409080637_r26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6890-11-6","article-title":"Effects of different centrifugation conditions on clinical chemistry and Immunology test results.","volume":"11","author":"Minder","year":"2011","journal-title":"BMC Clin Pathol"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/assets\/images\/upload\/xml_tif\/bm-36-2-020703.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:04:14Z","timestamp":1782396254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/36\/2\/10.11613\/BM.2026.020703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,24]]},"published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2026.020703","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}